ACIP recommendations on anti-virals for influenza

As the influenza season is still active, the ACIP has issued updated guidelines on the use of anti-viral agents in influenza. In summary, any patient sick enough to be hospitalized with suspected or confirmed influenza should be treated with oseltamivir or zanamivir. Although the most benefit is received in those treated within the first 48 hours of illness, hospitalized patients may still derive benefit after 48 hours and should be considered for treatment. Full recommendations are available on line (MMWR)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment